Thomson Reuters, a US-based provider of information for healthcare professionals, has launched Infection Xpert, a clinical intelligence dashboard. The tool is designed to help infection preventionists (IPs) manage and reduce hospital-acquired infections (HAIs), capture and submit mandated infection reporting metrics, and analyse hospital infection data to improve patient safety.
Infection Xpert uses evidence-based clinical decision support (CDS) rules to identify medical threats earlier. For instance, the tool automatically identifies patients exhibiting signs of a serious infection and in need of immediate attention. More than 70 hospitals now use this technology to monitor patients in real-time for high-risk conditions.
The Infection Xpert solution includes a library of pre-built CDS rules developed using Micromedex evidence-based reference processes. These rules cover high-priority categories such as multi-drug resistant organisms, clostridium difficile infection, methicillin-resistant staphylococcus aureus infection, and CDC-defined HAIs such as central line-associated bloodstream infection.
Using data aggregated from disparate information systems throughout the hospital, Infection Xpert seeks to present IPs with a single view of comprehensive data about their patients. This includes critical lab values, medication lists, vital signs, microbiology reports, demographics and transcribed reports. With Infection Xpert, they can submit, collect and report National Healthcare Safety Network event and denominator data.
The IP also can access patient-specific Micromedex reference information with a single click. With real-time access to comprehensive patient data and reference content, IPs are seen to be equipped with all the information they need to make fully informed treatment decisions.
Infection Xpert, part of the Clinical Xpert suite of workflow solutions can be integrated within any hospital IT environment.
Search for more Decision Support Tools
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
